Oncomine Breast cfTNA Assay
Introduction to the Oncomine Breast cfTNA Assay
The Oncomine Breast cfTNA Assay is a groundbreaking genetic test that plays a vital role in the detection and management of breast cancer. This assay is designed to analyze circulating tumor DNA (ctDNA) from a simple peripheral blood sample, providing critical insights into the genetic makeup of breast tumors. Understanding these genetic factors is essential for personalized treatment approaches, allowing healthcare providers to tailor therapies that are most effective for individual patients.
What the Test Measures
This assay detects specific genetic mutations associated with breast cancer. By analyzing ctDNA, the Oncomine Breast cfTNA Assay can identify alterations in genes that may influence the progression of the disease and the response to various treatment options. This information is invaluable for oncologists when determining the most appropriate therapeutic strategies.
Who Should Consider This Test?
Individuals who may benefit from the Oncomine Breast cfTNA Assay include:
- Patients with a family history of breast cancer.
- Individuals exhibiting symptoms such as unusual lumps or changes in breast tissue.
- Patients who have been diagnosed with breast cancer and are exploring targeted treatment options.
It is essential to consult with a healthcare provider to determine if this test is appropriate based on individual risk factors and medical history.
Benefits of Taking the Test
- Provides critical genetic information that can guide treatment decisions.
- Helps in monitoring treatment response and disease progression.
- Non-invasive testing through a simple blood draw.
- Can lead to more personalized and effective treatment plans.
Understanding Your Results
Results from the Oncomine Breast cfTNA Assay will provide insights into the presence of specific genetic mutations. It is crucial to discuss these results with your healthcare provider, who can explain their significance and how they may impact your treatment options. Understanding your results can empower you and your healthcare team to make informed decisions regarding your breast cancer management.
Test Pricing
| Test Name | Discount Price (NGN) | Regular Price (NGN) |
|---|---|---|
| Oncomine Breast cfTNA Assay | 1,050,000 NGN | 1,400,000 NGN |
Book the Test
The Oncomine Breast cfTNA Assay can be performed with a Doctor’s prescription. Please note that a prescription is not applicable for surgery and pregnancy cases or individuals planning to travel abroad. For more information or to schedule your test, contact us at +2348077798758 or visit our website to book your appointment today!
Turnaround time for results is typically 2-3 weeks, ensuring you receive timely information to aid in your treatment journey.
